» Articles » PMID: 22137795

Mosaic Amplification of Multiple Receptor Tyrosine Kinase Genes in Glioblastoma

Overview
Journal Cancer Cell
Publisher Cell Press
Specialty Oncology
Date 2011 Dec 6
PMID 22137795
Citations 405
Authors
Affiliations
Soon will be listed here.
Abstract

Tumor heterogeneity has been implicated in tumor growth and progression as well as resistance to therapy. We present an example of genetic heterogeneity in human malignant brain tumors in which multiple closely related driver genes are amplified and activated simultaneously in adjacent intermingled cells. We have observed up to three different receptor tyrosine kinases (EGFR, MET, PDGFRA) amplified in single tumors in different cells in a mutually exclusive fashion. Each subpopulation was actively dividing, and the genetic changes resulted in protein production, and coexisting subpopulations shared common early genetic mutations indicating their derivation from a single precursor cell. The stable coexistence of different clones within the same tumor will have important clinical implications for tumor resistance to targeted therapies.

Citing Articles

Spatial 3D genome organization reveals intratumor heterogeneity in primary glioblastoma samples.

Wang Q, Wang J, Mathur R, Youngblood M, Jin Q, Hou Y Sci Adv. 2025; 11(11):eadn2830.

PMID: 40073147 PMC: 11900876. DOI: 10.1126/sciadv.adn2830.


Glioblastoma multiforme: insights into pathogenesis, key signaling pathways, and therapeutic strategies.

Pouyan A, Ghorbanlo M, Eslami M, Jahanshahi M, Ziaei E, Salami A Mol Cancer. 2025; 24(1):58.

PMID: 40011944 PMC: 11863469. DOI: 10.1186/s12943-025-02267-0.


Bioengineered protein nanocarrier facilitating siRNA escape from lysosomes for targeted RNAi therapy in glioblastoma.

Jin Y, Zhang B, Li J, Guo Z, Zhang C, Chen X Sci Adv. 2025; 11(8):eadr9266.

PMID: 39970222 PMC: 11838010. DOI: 10.1126/sciadv.adr9266.


Isolation and Characterization of the First Antigen-Specific EGFRvIII vNAR from Freshwater Stingray ( spp.) as a Drug Carrier in Glioblastoma Cancer Cells.

Manzanares-Guzman A, Alfonseca-Ladron de Guevara A, Reza-Escobar E, Burciaga-Flores M, Canales-Aguirre A, Esquivel-Solis H Int J Mol Sci. 2025; 26(3).

PMID: 39940647 PMC: 11817625. DOI: 10.3390/ijms26030876.


Metabolomic characterisation of the glioblastoma invasive margin reveals a region-specific signature.

Wood J, Smith S, Castellanos-Uribe M, Lourdusamy A, May S, Barrett D Heliyon. 2025; 11(1):e41309.

PMID: 39816516 PMC: 11732679. DOI: 10.1016/j.heliyon.2024.e41309.